Kategorien
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
661
Antibiotics
247
Bioactive Small Molecules
714
Aroma Chemicals
203
Biochemicals
998
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
52
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
254
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
322
Ion-Pair Reagents
24
Ligands
79
Organics
1288
Oxazoles
3
Peptide Reagents
90
Phenols
46
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
43
Reagents
97
Research Organics & Inorganics
747
Salts
282
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
290
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
90
Water Analysis
11
Ciclopirox olamine
(21723158 | 41621-49-2)
CAS: | 41621-49-2 |
---|---|
Molekularformel: | C12H17NO2 · C2H7NO |
Molekulargewicht: | 268.35 |
Verfügbarkeit: | Auf Lager |
---|---|
Downloads: | | |
Für dieses Produkt wird ein Gefahrstoffzuschlag erhoben. Der genaue Betrag wird von unserem Verkaufsteam bestätigt.
21723158-1g | 1g | £37.30 | |
Bulk Menge |
21723158-1g | 1g | €52.30 | |
Bulk Menge |
21723158-1g | 1g | $56.00 | |
Bulk Menge |
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
Product Code | 21723158 | ||||
Product Name | Ciclopirox olamine | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 41621-49-2 | ||||
Molecular Formula | C12H17NO2 · C2H7NO | ||||
Molecular Weight | 268.35 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2933790090 |
Produktspezifikation
pH | 8.0-9.0 | ||||
Loss on Drying | ≤1.0% | ||||
Assay | ≥99% | ||||
Residue on Ignition | ≤0.1% | ||||
Appearance | White/ off white powder | ||||
Melting Range | 124.0-128.0 °C | ||||
Heavy metal content | ≤20 ppm |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|